Apollon Financial’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Apollon Financial's LLY Position: Q3 2026 in Review
Apollon Financial increased its Eli Lilly (LLY) stake by 5.6% in Q3 2026, buying an estimated $130K and bringing the position to 2,073 shares worth $2.4M. The position accounts for 0.27% of the portfolio, ranked #84.
Apollon Financial first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. 3,033 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Apollon Financial held 2,073 shares of Eli Lilly worth $2.4M as of Q3 2026.
- Apollon Financial bought 110 Eli Lilly shares in Q3 2026, an estimated $130K.
- Eli Lilly made up 0.27% of Apollon Financial's portfolio in Q3 2026, its #84 holding.
- Apollon Financial first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
- 3,033 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Apollon Financial's 13F filing for Q3 2026, filed 23 Oct 2026.